BEIJING - Sinovac Biotech Ltd said its coronavirus shot is safe and capable of eliciting an immune response from human trials, suggesting the shot's potential in defending against infection of the novel coronavirus.
The preliminary findings come from phase I and II trials in China. A total of 743 healthy people ages 18 to 59 either received shots on two schedules or a placebo. Using a killed version of the coronavirus, Sinovac's vaccine is among five Chinese experimental shots that have reached the crucial final stage of human testing before they can be approved for public use.
Chinese snake oil.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: